Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)

PHASE2TerminatedINTERVENTIONAL
Enrollment

268

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Schizophrenia
Interventions
DRUG

ABT-126

capsule(s)

Trial Locations (51)

11516

Site Reference ID/Investigator# 95379, Cedarhurst

14623

Site Reference ID/Investigator# 95392, Rochester

19139

Site Reference ID/Investigator# 95388, Philadelphia

30060

Site Reference ID/Investigator# 95377, Marietta

30308

Site Reference ID/Investigator# 95399, Atlanta

60169

Site Reference ID/Investigator# 129380, Hoffman Estates

60640

Site Reference ID/Investigator# 120595, Chicago

75115

Site Reference ID/Investigator# 95402, DeSoto

77008

Site Reference ID/Investigator# 95393, Houston

90502

Site Reference ID/Investigator# 95387, Torrance

90650

Site Reference ID/Investigator# 95390, Norwalk

90660

Site Reference ID/Investigator# 95395, Pico Rivera

91710

Site Reference ID/Investigator# 95398, Chino

91776

Site Reference ID/Investigator# 95384, San Gabriel

91950

Site Reference ID/Investigator# 95378, National City

92025

Site Reference ID/Investigator# 95400, Escondido

92056

Site Reference ID/Investigator# 95391, Oceanside

92102

Site Reference ID/Investigator# 95405, San Diego

92103

Site Reference ID/Investigator# 95397, San Diego

92408

Site Reference ID/Investigator# 128356, San Bernardino

92506

Site Reference ID/Investigator# 95403, Riverside

92626

Site Reference ID/Investigator# 95381, Costa Mesa

92705

Site Reference ID/Investigator# 95385, Santa Ana

92845

Site Reference ID/Investigator# 95406, Garden Grove

92868

Site Reference ID/Investigator# 95380, Orange

94612

Site Reference ID/Investigator# 95386, Oakland

109559

Site Reference ID/Investigator# 117159, Moscow

115419

Site Reference ID/Investigator# 117183, Moscow

150003

Site Reference ID/Investigator# 117181, Yaroslavl

190020

Site Reference ID/Investigator# 117157, Saint Petersburg

190121

Site Reference ID/Investigator# 117185, Saint Petersburg

191119

Site Reference ID/Investigator# 117192, Saint Petersburg

Site Reference ID/Investigator# 117193, Saint Petersburg

192019

Site Reference ID/Investigator# 117176, Saint Petersburg

195176

Site Reference ID/Investigator# 117195, Saint Petersburg

197341

Site Reference ID/Investigator# 117186, Saint Petersburg

357034

Site Reference ID/Investigator# 117180, Stavropol

399083

Site Reference ID/Investigator# 117175, Lipetsk

410028

Site Reference ID/Investigator# 117156, Saratov

410060

Site Reference ID/Investigator# 117177, Saratov

420061

Site Reference ID/Investigator# 117188, Kazan'

620028

Site Reference ID/Investigator# 117194, Yekaterinburg

620030

Site Reference ID/Investigator# 117178, Yekaterinburg

630091

Site Reference ID/Investigator# 117182, Novosibirsk

672090

Site Reference ID/Investigator# 117189, Chita

06519

Site Reference ID/Investigator# 95382, New Haven

EH10 5HF

Site Reference ID/Investigator# 117422, Edinburgh

SE5 8AF

Site Reference ID/Investigator# 117423, London

W6 8RP

Site Reference ID/Investigator# 117425, London

NE4 5PL

Site Reference ID/Investigator# 117424, Newcastle upon Tyne

OX3 7JX

Site Reference ID/Investigator# 117419, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY